Chemoinformaics analysis of Lupinisoflavone G
| Molecular Weight | 422.477 | nRot | 4 |
| Heavy Atom Molecular Weight | 396.269 | nRig | 23 |
| Exact Molecular Weight | 422.173 | nRing | 4 |
| Solubility: LogS | -2.996 | nHRing | 2 |
| Solubility: LogP | 5.28 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 63.8986 |
| nHD | 3 | BPOL | 30.4234 |
| QED | 0.537 |
| Synth | 3.623 |
| Natural Product Likeliness | 2.538 |
| NR-PPAR-gamma | 0.978 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.044 |
| Pgp-sub | 0.049 |
| HIA | 0.02 |
| CACO-2 | -4.679 |
| MDCK | 0.0000119 |
| BBB | 0.008 |
| PPB | 0.948078 |
| VDSS | 0.539 |
| FU | 0.0527024 |
| CYP1A2-inh | 0.362 |
| CYP1A2-sub | 0.192 |
| CYP2c19-inh | 0.605 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.616 |
| CYP2c9-sub | 0.892 |
| CYP2d6-inh | 0.527 |
| CYP2d6-sub | 0.394 |
| CYP3a4-inh | 0.188 |
| CYP3a4-sub | 0.14 |
| CL | 4.376 |
| T12 | 0.359 |
| hERG | 0.015 |
| Ames | 0.023 |
| ROA | 0.809 |
| SkinSen | 0.776 |
| Carcinogencity | 0.098 |
| EI | 0.266 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.865 |
| Antiviral | Yes |
| Prediction | 0.886418 |